On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.

NeurAxis (NASDAQ:NRXS – Get Free Report) and Medtronic (NYSE:MDT – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength ...

The pulse oximeter, a device that measures the degree to which red blood cells are saturated with oxygen, is one of healthcare's most fundamental tools.

Global Remote Patient Monitoring Market is estimated to be valued at $40B in 2023, expected to grow at CAGR of ~12% during the forecast period (2024 – 2030) ...

(GPx), a fast-growing MedTech startup revolutionizing chronic disease monitoring and management ... and sales in healthcare and medical devices. Its co-founders Sean Matsuoka and Javier Echenique have ...

Kamen and Sequel Medtech CEO Alan Lotvin say they are offering greater precision in insulin delivery with new pump technology ...

This growth is primarily driven by the rising prevalence of cardiovascular diseases (CVDs) worldwide, alongside continuous ...

The global gastroesophageal reflux disease (GERD) device market is positioned for substantial growth over the next decade, ...

The Surgical Equipment Market, valued at USD 35.41 billion in 2023, is expected to grow at a compound annual growth rate (CAGR) of 9.74 ...

Boston Scientific is resuming its "Avant Guard" study of pulse field ablation (PFA) as a first-line therapy for atrial ...